3 results
The primary objective of this study is to test the hypothesis that evacetrapib 130 mg daily, in comparison to placebo, reduces the incidence of the composite endpoint of cardiovascular (CV) death, myocardial infarction (MI), stroke, coronary…
The aim of this study is to assess the effects and side effects of the QWhet micro current wound stimulation device in up to 78 subjects with a chronic wound over a continuous period of 28 days.The collected (coded) data will be used by Q Care to…
The primary objective will be to investigate if a two-year course of TPTD followed by antiresorptive treatment with a single infusion of ZA in adults with OI reduces the proportion of patients who experience a fracture as compared with standard care…